pd 153035 and su 9516

pd 153035 has been researched along with su 9516 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M	1
Dong, Z; Fu, L; Gao, X; Ji, C; Li, L; Liu, H; Luo, X; Mei, C; Xiong, X; Zhang, Y	1

Other Studies

2 other study(ies) available for pd 153035 and su 9516

Article	Year
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases. Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51 Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases	2007
B5, a novel pyrrole-substituted indolinone, exerts potent antitumor efficacy through G2/M cell cycle arrest. Investigational new drugs, 2010, Volume: 28, Issue:1 Topics: Antineoplastic Agents; Bromodeoxyuridine; CDC2 Protein Kinase; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin B1; Drug Screening Assays, Antitumor; Enzyme-Linked Immunosorbent Assay; ErbB Receptors; G2 Phase; Humans; Imidazoles; Indoles; Mitosis; Pyrroles; Quinazolines	2010

Article

Year

A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.

Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007

B5, a novel pyrrole-substituted indolinone, exerts potent antitumor efficacy through G2/M cell cycle arrest.

Investigational new drugs, 2010, Volume: 28, Issue:1

Topics: Antineoplastic Agents; Bromodeoxyuridine; CDC2 Protein Kinase; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin B1; Drug Screening Assays, Antitumor; Enzyme-Linked Immunosorbent Assay; ErbB Receptors; G2 Phase; Humans; Imidazoles; Indoles; Mitosis; Pyrroles; Quinazolines

2010